Far East Growth – Inflation driving up costs? Your solution lies in Asia (May 2017)

Inflation driving up costs? Your solution lies in Asia

As inflation starts to rise, investors look for companies able to maintain profit margins. However, the real prize will go to businesses that do not just cut their own costs, but offer services and products that can help other companies become more efficient. That includes the providers of technologies such as automation, 3D printing and the Internet of Things.


The US, Europe and Japan lead the automation industry, but as Asia’s giant supply chain faces rapidly rising wages, the need for cost reductions is driving huge growth in domestic solutions. As new factories are built in Asia, companies typically start with at least 20-50% of their plant already automated. Until now German and Japanese technology have been most popular, but increasingly companies are turning to machinery made in China, using components made in Taiwan and Korea. According to Global Automation Research, Asian suppliers of this machinery are growing faster than their US, European and Japanese counterparts, and the Asian companies we meet in this space are typically posting earnings growth of circa 25-40% per annum.

3D Printing

3D printing has captured the imagination of the world. It saves money at every stage of the manufacturing process, from design (circa 90% time savings) to manufacture (circa 30% of materials costs) to transportation (potentially almost all of it). Asia has taken this new technology to heart and while the West may have pioneered 3D printing, the Koreans, backed by favourable regulation, lead the world in 3D bio-printing. The country was the first to approve 3D-printed cranial implants and has developed open source bioprinters. Now, 3D-printed heel bone implants save weeks of medical costs once spent waiting for matching bone tissue.

In China, Shanghai-based Jala Group and its French joint venture partner, LabSkin, are printing human skin. Organovo first commercialised this technology in the US and both are now running neck and neck with Spanish supplier BioDan. However, Jala has a vast domestic market and favourable regulation behind it, enabling Asia’s cosmetics and pharmaceutical companies to gain a competitive advantage and dramatically reduce thecosts associated with testing on animals. How long before the West knocks on their door?

Internet of Things

But what if 3D printing or automation really do not suit your business? Asia is the home of wireless technology, of radiofrequency identification (RFID), CCTV cameras, semiconductor chips, sensors and drones. As the Internet of Things connects everything, Taiwan’s vast brandagnostic supply chain is leading in almost every area. Years of pressure from Apple and the giant multinationals have bred a culture of innovation in cost control and now they look poised to reap the rewards.

So, whether it is monitoring your crops by drone, integrating your salesforce with personal wifi or just beaming your service to consumers in their own homes by wifi, the widgets and gadgets that make that possible almost all come from Asia. Behind those connected items, there is probably a Taiwanese Wistron NeWeb antenna or Sercomm Home Gateway router.

At a time of rising inflation, it pays businesses that want to improve their efficiency to look East to Asian companies at the forefront of so many cost-cutting technologies. For investors too, we believe a number of these companies offer attractive opportunities.

Sally Macdonald is the Head of Asian Equities at Marlborough Fund Managers. A version of this article was first published by Fund Strategy.

Regulatory Information and Risk Warning

The past is not necessarily a guide to future performance. The value of investments and the income from them may fall as well as rise and you may not get back the amount you originally invested. Changes in exchange rates may cause the value of the fund to rise or fall. The Fund invests in less developed overseas markets which may be less liquid and more volatile than more developed markets. The Fund has a concentrated portfolio which means greater exposure to a smaller number of securities than a more diversified portfolio. You are required to read the Key Investor Information Document (KIID) before making an investment. The KIID and prospectus for all funds are available free of charge at marlboroughfunds.com or by calling 0808 145 2500. This document is provided for information purposes only and should not be interpreted as investment advice. The information contained herein has been prepared from sources believed reliable but is not guaranteed and is not a complete summary or statement of all available data, nor is it considered an offer to buy or sell any securities referred to herein. Opinions expressed are subject to change without notice and do not take into account the particular investment objectives, financial situations or need of individual investors. Please note that for your protection telephone calls may be recorded.